Physician

Adele Marie Guernica, D.O.

According to 2025 Medicare claims, Adele Guernica, D.O. (NPI: 1073547048) practices allergy/immunology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is PA ALLERGY & ASTHMA CONSULTANTS (NPI: 1770741035; TIN: 261592260) and primary practice location at 19426-3625.

Guernica's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 155 traditional Medicare patients, billed 12,757 HCPCS/CPT codes, and received $297,382 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 404 prescription claims across 98 beneficiaries totaling $132,883 in drug costs, led by Xolair (Omalizumab). DME data shows 29 claims. Open Payments data shows 12 records totaling $302. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $24,404 to $297,382. Similarly, Part D prescription costs have moved sharply higher in recent years, from $32,089 to $132,883. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $755 and ending at $698.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	71	1,914	$24,404
2016	71	1,475	$19,546
2017	68	1,205	$14,885
2018	84	2,244	$25,322
2019	88	2,206	$26,314
2020	96	1,819	$19,764
2021	115	2,278	$33,235
2022	164	6,720	$127,717
2023	158	7,989	$217,385
2024	155	12,757	$297,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	271	$32,089
2016	62	350	$25,467
2017	67	293	$28,712
2018	63	275	$43,304
2019	69	244	$52,866
2020	65	273	$82,273
2021	105	376	$123,638
2022	103	378	$168,768
2023	91	387	$142,396
2024	98	404	$132,883

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$696
2016	N/R	36	$683
2017	N/R	15	$362
2018	N/R	13	$46,929
2019	N/R	11	$42,374
2020	N/R	23	$49,035
2021	N/R	11	$47,387
2022	N/R	14	$59,370
2023	N/R	64	$213,108
2024	N/R	29	$82,048

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	42	42	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	107	150	$63
95165	Professional service for preparation and provision of 1 or more antigens	30	1,240	$11
95117	Professional service for multiple injections of allergen	35	417	$9
95004	Test for allergy using allergenic extract	25	953	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	15	420	$41,627
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	630	$1,380
Hydroxyzine Hcl	Hydroxyzine Hcl	30	1,225	$1,218
Azelastine Hcl	Azelastine Hcl	23	1,560	$1,053
Desloratadine	Desloratadine	15	1,290	$1,007

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	18	$81,902
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	N	N/R	11	$146

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$302	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adele Marie Guernica, D.O.?

Tedicare shows public-source Medicare data for Adele Marie Guernica, D.O. (NPI 1073547048), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adele Marie Guernica, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adele Marie Guernica, D.O.?

Adele Marie Guernica, D.O. is linked to PA ALLERGY & ASTHMA CONSULTANTS (billing NPI 1770741035) in the available physician profile data.

Does Adele Marie Guernica, D.O. have Open Payments data?

Adele Marie Guernica, D.O. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.